Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Amgen Reports Positive Phase 3 Data For Uplizna
AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
Amgen (NASDAQ:AMGN) today announced the presentation of positive top-line results from the Phase 3 MINT trial evaluating the efficacy and safety of UPLIZNA® (inebilizumab-cdon) for the treatment of adults with generalized myasthenia gravis (gMG),
Amgen Reports Positive Phase 3 Data For Uplizna In Generalized Myasthenia Gravis
Tuesday announced positive topline data from the Phase 3 MINT study evaluating Uplizna for the treatment of adults
Amgen Myasthenia Gravis Drug Meets Primary Goal in Phase 3 Trial
Amgen said it achieved positive results from a Phase 3 trial of its treatment for adults with generalized myasthenia gravis, a rare autoimmune disorder.
2d
Cautious Optimism: Amgen’s Uplizna Shows Promise but Limited Immediate Impact on Valuation
Analyst Mohit Bansal of Wells Fargo maintained a Hold rating on Amgen (AMGN – Research Report), retaining the price target of $335.00.
FiercePharma
23d
With success in myasthenia gravis trial, Amgen's Uplizna looks set up to add new indication
Uplizna
was one of the key drugs acquired from the company’s $27.8 billion acquisition of Horizon Therapeutics, which was completed in October of last year. Amgen
Uplizna
Myasthenia Gravis ...
23d
on MSN
Amgen stock slides 5% as analysts weigh in on drug study results (update)
Amgen (NASDAQ:AMGN) shares were down 5% Wednesday, the day after the company reported Phase 3 results for its drugs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Judge unseals new evidence
Preliminary cause of death
School shooting report
NC breaks turnout record
La Nina could arrive soon
Republicans appeal ruling
Three Americans detained
Fire prompts evacuations
PG&E shuts off power
NYC giant pigeon sculpture
OK classroom Bible suit
Ex-MN congressman dies
Calif. oil refinery closure
Musk's first Trump event
Lebanese citizens get TPS
‘Full Self-Driving’ probe
Bladder cancer drug pulled
Nevada US Senate debate
$4M LAPD fentanyl seizure
To furlough 700 workers
NK sending troops to RU?
Eases voting rules
Dow closes at record high
School shooting indictment
988 Lifeline georouting
US charges ex-Indian spy
Teen tobacco use falls
Emergency abortion ruling
Space export curbs eased
At decade-high level
FAA opens new safety review
Related topics
Amgen
Myasthenia gravis
Feedback